Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Heska Schedules Second Quarter 2018 Financial Results Conference Call for August 7, 2018

Heska Corporation
Posted on: 18 Jul 18
Heska Schedules Second Quarter 2018 Financial Results Conference Call for August 7, 2018

PR Newswire

LOVELAND, Colo., July 18, 2018

LOVELAND, Colo., July 18, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to announce its second quarter 2018 financial results in a press release to be issued on Tuesday, August 7, 2018 before the market opens. The Company plans to host a conference call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day, Tuesday, August 7, 2018.

To access the conference call:

    From within the United States, please dial 1-888-394-8218

    From outside of the United States, please dial 1-323-701-0225

    Reference Conference ID: 9053418

The conference call will be webcast live from the Company's website on www.heska.com.

A telephonic replay of the conference call will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Tuesday, August 14, 2018.

To access the replay:

    From within the United States, please dial 1-844-512-2921

    From outside the United States, please dial 1-412-317-6671

    Reference Replay Pin Number: 9053418

The webcast will also be archived on www.heska.com for 90 days.

About Heska

Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") and Other Vaccines, Pharmaceuticals and Products ("OVP"). CCA includes, primarily for canine and feline use, point of care laboratory testing instruments and supplies under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.

 

View original content:http://www.prnewswire.com/news-releases/heska-schedules-second-quarter-2018-financial-results-conference-call-for-august-7-2018-300682291.html

SOURCE Heska Corporation

PR Newswire
www.prnewswire.com

Last updated on: 18/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.